Disulfide based prodrugs for cancer therapy-Reference-Cited by-同舟云学术

Disulfide based prodrugs for cancer therapy

Published:2020 Issue:41 Volume:10 Page:24397-24409
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Wang Qiang¹²³⁴⁵,Guan Jiankun¹²³⁴⁵,Wan Jiangling¹²³⁴⁵,Li Zifu¹²³⁴⁵^ORCID

Affiliation:

1. National Engineering Research Center for Nanomedicine

2. College of Life Science and Technology

3. Huazhong University of Science and Technology

4. Wuhan

5. China

Abstract

This review summarizes the progress in disulfide linker technology to balance extracellular stability and intracellular cleavage for optimized disulfide-containing prodrugs.

Funder

National Natural Science Foundation of China

Huazhong University of Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/RA/D0RA04155F

Reference115 articles.

1. Prodrugs: design and clinical applications

2. Prodrug approach: An overview of recent cases

3. The expanding role of prodrugs in contemporary drug design and development

4. Mutual prodrug concept: Fundamentals and applications

5. Novel Mutual Prodrug of Retinoic and Butyric Acids with Enhanced Anticancer Activity

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in polysulfide-based prodrug nanomedicines for cancer therapy;Coordination Chemistry Reviews;2024-11

2. Liposomal delivery of organoselenium-cisplatin complex as a novel therapeutic approach for colon cancer therapy;Colloids and Surfaces B: Biointerfaces;2024-10

3. Psammaplin A analogues with modified disulfide bond targeting histone deacetylases: Synthesis and biological evaluation;European Journal of Medicinal Chemistry;2024-09

4. Use of a Cyclic α-Alkylidene-β-Diketone as a Cleavable Linker Strategy for Antibody-Drug Conjugates;Journal of the American Chemical Society;2024-08-15

5. Design of pH/Redox Co-Triggered Degradable Diselenide-Containing Polyprodrug via a Facile One-Pot Two-Step Approach for Tumor-Specific Chemotherapy;Molecules;2024-08-13